| Name | Elmhaven East |
|---|---|
| Location | 1400 S 15th Street, Parsons, Kansas |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 45 |
| Occupancy Rate | 68% |
| Medicare ID (CCN) | 175415 |
| Legal Business Name | Woodworth Enterprises, Inc. |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1487657581 |
| Organization Name | WOODWORTH ENTERPRISES, INC. |
| Doing Business As | ELMHAVEN EAST |
| Address | 1400 S 15th St, Parsons, KS 67357 |
| Phone Number | 620-421-1430 |
News Archive
Researchers from the Arthritis Research UK Pain Centre at The University of Nottingham have discovered a new way to potentially block the chronic and often debilitating pain affecting osteoarthritis sufferers.
Scientists have uncovered an alternative source for some of the damage associated with multiple sclerosis, an incurable neuroinflammatory disorder. The research, published online by Cell Press on September 23rd in the journal Immunity, reveals a direct interaction between immune cells and neurons that plays a significant role in neuronal injury and may respond to therapeutic intervention.
The Hill reports that, according to an analysis by the American Action Forum, the Department of Health and Human Services has missed many implementation deadlines in the last two years. Meanwhile, Politico Pro examines issues related to the health law's Medicaid expansion and exchange subsidies.
A new study by researchers at the Institute of Psychiatry (IoP), King's College London has discovered abnormalities in the white matter of the brain that seem to be critical for the timing of schizophrenia. The study, led by Professor Phillip McGuire and Dr Sophia Frangou, has been published in this month's edition of the British Journal of Psychiatry.
The Pulmonary Fibrosis Foundation (PFF) today announced that the Pulmonary Fibrosis Research Enhancement Act (PFREA) was introduced in the United States Senate. The PFREA was introduced by Senators Patty Murray (D-WA) and Mike Crapo (R-ID), and the PFF has offered its unconditional endorsement to pass this important legislation on behalf of the pulmonary fibrosis community.
› Verified 1 days ago
| NPI Number | 1740272244 |
| Organization Name | WOODWORTH ENTERPRISES, INC. |
| Doing Business As | ELMHAVEN WEST |
| Address | 1315 S 15th St, Parsons, KS 67357 |
| Phone Number | 620-421-1320 |
News Archive
Researchers from the Arthritis Research UK Pain Centre at The University of Nottingham have discovered a new way to potentially block the chronic and often debilitating pain affecting osteoarthritis sufferers.
Scientists have uncovered an alternative source for some of the damage associated with multiple sclerosis, an incurable neuroinflammatory disorder. The research, published online by Cell Press on September 23rd in the journal Immunity, reveals a direct interaction between immune cells and neurons that plays a significant role in neuronal injury and may respond to therapeutic intervention.
The Hill reports that, according to an analysis by the American Action Forum, the Department of Health and Human Services has missed many implementation deadlines in the last two years. Meanwhile, Politico Pro examines issues related to the health law's Medicaid expansion and exchange subsidies.
A new study by researchers at the Institute of Psychiatry (IoP), King's College London has discovered abnormalities in the white matter of the brain that seem to be critical for the timing of schizophrenia. The study, led by Professor Phillip McGuire and Dr Sophia Frangou, has been published in this month's edition of the British Journal of Psychiatry.
The Pulmonary Fibrosis Foundation (PFF) today announced that the Pulmonary Fibrosis Research Enhancement Act (PFREA) was introduced in the United States Senate. The PFREA was introduced by Senators Patty Murray (D-WA) and Mike Crapo (R-ID), and the PFF has offered its unconditional endorsement to pass this important legislation on behalf of the pulmonary fibrosis community.
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Researchers from the Arthritis Research UK Pain Centre at The University of Nottingham have discovered a new way to potentially block the chronic and often debilitating pain affecting osteoarthritis sufferers.
Scientists have uncovered an alternative source for some of the damage associated with multiple sclerosis, an incurable neuroinflammatory disorder. The research, published online by Cell Press on September 23rd in the journal Immunity, reveals a direct interaction between immune cells and neurons that plays a significant role in neuronal injury and may respond to therapeutic intervention.
The Hill reports that, according to an analysis by the American Action Forum, the Department of Health and Human Services has missed many implementation deadlines in the last two years. Meanwhile, Politico Pro examines issues related to the health law's Medicaid expansion and exchange subsidies.
A new study by researchers at the Institute of Psychiatry (IoP), King's College London has discovered abnormalities in the white matter of the brain that seem to be critical for the timing of schizophrenia. The study, led by Professor Phillip McGuire and Dr Sophia Frangou, has been published in this month's edition of the British Journal of Psychiatry.
The Pulmonary Fibrosis Foundation (PFF) today announced that the Pulmonary Fibrosis Research Enhancement Act (PFREA) was introduced in the United States Senate. The PFREA was introduced by Senators Patty Murray (D-WA) and Mike Crapo (R-ID), and the PFF has offered its unconditional endorsement to pass this important legislation on behalf of the pulmonary fibrosis community.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 3 |
| Total Amount of Fines in Dollars | $31850 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 3 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 15.89 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 13.46 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 25.45 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.29 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 5.98 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.33 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 66.67 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 18.69 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 38.18 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 21.14 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 14.02 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 14.1 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |